Kalehua Capital Management LLC
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 13, 2026), Kalehua Capital Management LLC reported 19 stock positions worth $101.1 million. Its top holding was Alpha Architect 1-3 MNTH Box (BOXX) at 26.3% of the portfolio, followed by X4 Pharmaceuticals (XFOR, 14.7%) and Sionna Therapeutics (SION, 8.0%).
- Most Recent 13F
- Q2 2026
- Location
- DALLAS, TX
- CIK
- 0002106181
- Portfolio Value
- $101.1M (Q4 2025)
- SEC Filing
- 0002106181-26-000003 ↗ filed Feb 13, 2026
Holdings Value
Holdings 19 stocks · $101.1M
| BOXX Alpha Architect 1-3 MNTH Box | 26.27% | 230,787 | $26.6M | — |
| XFOR X4 Pharmaceuticals Inc. | 14.73% | 3,722,840 | $14.9M | — |
| SION Sionna Therapeutics Inc. | 8.02% | 197,072 | $8.1M | — |
| RLAY Relay Therapeutics Inc. | 7.54% | 901,457 | $7.6M | — |
| CMPS Compass Pathways PLC | 5.59% | 819,692 | $5.7M | — |
| PHVS Pharvaris NV | 5.46% | 198,772 | $5.5M | — |
| SEPN Septerna Inc. | 5.36% | 194,544 | $5.4M | — |
| ORKA Oruka Therapeutics Inc. | 3.55% | 118,524 | $3.6M | — |
| IKT Inhibikase Therapeutics Inc. | 3.55% | 1,750,000 | $3.6M | — |
| ALLO Allogene Therapeutics Inc. | 3.45% | 2,546,129 | $3.5M | — |
| LONA Leonabio Inc. filed as ATHIRA PHARMA INC | 2.95% | 393,701 | $3.0M | — |
| MLTX Moonlake Immunotherapeutics | 2.29% | 175,734 | $2.3M | — |
| ORIC Oric Pharmaceuticals Inc. | 2.16% | 267,059 | $2.2M | — |
| VRCA Verrica Pharmaceuticals Inc. | 1.94% | 235,779 | $2.0M | — |
| TYRA Tyra Biosciences Inc. | 1.94% | 74,465 | $2.0M | — |
| SRZN Surrozen Inc. | 1.87% | 385,178 | $1.9M | — |
| TNYA Tenaya Therapeutics Inc. | 1.41% | 2,000,000 | $1.4M | — |
| KLRS Kalaris Therapeutics Inc. | 1.17% | 139,901 | $1.2M | — |
| DMAC Diamedica Therapeutics Inc. | 0.75% | 95,359 | $759K | — |
Portfolio Sells Q4 2025
No earlier filing to compare with.
Portfolio Buys Q4 2025
No earlier filing to compare with.